Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development (Q39976180)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development |
scientific article |
Statements
1 reference
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development (English)
1 reference
Mark Kester
1 reference
Melissa A Tran
1 reference
Charles D Smith
1 reference
Gavin P Robertson
1 reference
1 June 2008
1 reference
1 reference
3571-3581
1 reference
Identifiers
1 reference